Akadeum to Highlight Latest Accomplishments for Microbubble Cell Separation at Biotech Showcase 2026
Event Start Date: JAN 12, 2026 Share
Akadeum Life Sciences CEO, Dr. Brandon McNaughton, is scheduled to present the at the 2026 Biotech Showcase™ in San Francisco, CA. McNaughton will highlight robust data, regulatory achievements, and compelling ROI figures for Akadeum’s patented microbubble cell separation technology.
Since last year’s presentation, Akadeum has collaborated with Charles River, Lonza, MaxCyte, ElevateBio, and other industry leaders to generate new data showing how Akadeum’s buoyancy-based microbubble technology outperforms traditional magnetic methods in yield, quality, and cost efficiency. This data also supports new ROI figures showing 40% overall cost savings when microbubbles are integrated into current cell therapy workflows.
Akadeum has also achieved significant regulatory progress, highlighted by their recent Drug Master File (DMF) submission to the US FDA for its GMP BACS™ Microbubble Cell Separation products.
McNaughton will highlight these accomplishments in his Showcase Presentation as well as what Akadeum hopes to achieve in 2026 to help make cell therapy more affordable and accessible.
Presentation Details:
- Date: Monday, January 12
- Time: 10:30AM
- Location: Franciscan B (Ballroom Level)
Interested in connecting with Akadeum before, during, or after the event?
Contact our team to schedule a meeting. Or follow us on LinkedIn for the latest information.
About Biotech Showcase
Biotech Showcase is a premier investor and partnering conference that connects private and micro- to mid-cap biotechnology companies with the global investment community and biopharma executives. The annual event provides a forum for emerging innovators to highlight their technologies, foster partnerships, and accelerate development across diverse therapeutic and life science sectors.